Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19

Detalles Bibliográficos
Autores principales: Vityala, Yethindra, Tagaev, Tugolbai, Mamatov, Sagynali, Aidarov, Ziiabidin, Harinath, Panchadcharam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262423/
https://www.ncbi.nlm.nih.gov/pubmed/34169913
http://dx.doi.org/10.4103/ijp.IJP_33_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262423/
https://www.ncbi.nlm.nih.gov/pubmed/34169913
http://dx.doi.org/10.4103/ijp.IJP_33_21

Ejemplares similares